These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 26084337

  • 21. Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study.
    López-Alarcón M, Montalvo-Velarde I, Vital-Reyes VS, Hinojosa-Cruz JC, Leaños-Miranda A, Martínez-Basila A.
    BJOG; 2015 Nov; 122(12):1586-92. PubMed ID: 26213116
    [Abstract] [Full Text] [Related]

  • 22. Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
    Jud P, Hafner F, Verheyen N, Gary T, Meinitzer A, Brodmann M, Seinost G, Hackl G.
    Heart Vessels; 2018 Dec; 33(12):1453-1462. PubMed ID: 29946762
    [Abstract] [Full Text] [Related]

  • 23. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, Bóveda J, de Lis JP, Fernández JR, Hermida RC, Hygia Project Investigators.
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [Abstract] [Full Text] [Related]

  • 24. Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease.
    Shi B, Ni Z, Zhou W, Yu Z, Gu L, Mou S, Fang W, Wang Q, Cao L, Yan Y, Qian J.
    Eur J Intern Med; 2010 Oct; 21(5):444-8. PubMed ID: 20816602
    [Abstract] [Full Text] [Related]

  • 25. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 26. Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake.
    El-Mesallamy HO, Abdel Hamid SG, Gad MZ.
    Kidney Blood Press Res; 2008 Aug; 31(3):189-95. PubMed ID: 18511874
    [Abstract] [Full Text] [Related]

  • 27. Plasma Homocysteine and Cardiovascular Organ Damage in a Population with a High Prevalence of Risk Factors.
    Kozakova M, Morizzo C, Penno G, Shore AC, Nilsson J, Palombo C.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32453833
    [Abstract] [Full Text] [Related]

  • 28. Association of homocysteine, asymmetric dimethylarginine, and nitric oxide with preeclampsia.
    Mao D, Che J, Li K, Han S, Yue Q, Zhu L, Zhang W, Li L.
    Arch Gynecol Obstet; 2010 Oct 01; 282(4):371-5. PubMed ID: 19806356
    [Abstract] [Full Text] [Related]

  • 29. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
    Notsu Y, Yano S, Shibata H, Nagai A, Nabika T.
    Atherosclerosis; 2015 Mar 01; 239(1):61-6. PubMed ID: 25576847
    [Abstract] [Full Text] [Related]

  • 30. Homocysteine is Associated with Exaggerated Morning Blood Pressure Surge in Patients with Acute Ischemic Stroke.
    Xie JC, Lin YY, Liu XH, Zhao YC, Ma XY, Yu J, Liu XY, Zhao YX.
    J Stroke Cerebrovasc Dis; 2018 Oct 01; 27(10):2650-2656. PubMed ID: 29960667
    [Abstract] [Full Text] [Related]

  • 31. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients.
    Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I, Böger R, CREED Investigators.
    Kidney Int; 2002 Jul 01; 62(1):339-45. PubMed ID: 12081596
    [Abstract] [Full Text] [Related]

  • 32. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine-NO pathway metabolite levels in patients with psoriasis.
    Bilgiç Ö, Altınyazar HC, Baran H, Ünlü A.
    Arch Dermatol Res; 2015 Jul 01; 307(5):439-44. PubMed ID: 25708188
    [Abstract] [Full Text] [Related]

  • 33. Left ventricular hypertrophy in nondiabetic predialysis CKD.
    Paoletti E, Bellino D, Cassottana P, Rolla D, Cannella G.
    Am J Kidney Dis; 2005 Aug 01; 46(2):320-7. PubMed ID: 16112052
    [Abstract] [Full Text] [Related]

  • 34. Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status.
    Herrmann W, Isber S, Obeid R, Herrmann M, Jouma M.
    Clin Chem Lab Med; 2005 Aug 01; 43(10):1139-46. PubMed ID: 16197311
    [Abstract] [Full Text] [Related]

  • 35. Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes.
    Heilman K, Zilmer M, Zilmer K, Kool P, Tillmann V.
    Scand J Clin Lab Invest; 2009 Aug 01; 69(1):85-91. PubMed ID: 18830896
    [Abstract] [Full Text] [Related]

  • 36. Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry.
    Pecchini P, Malberti F, Mieth M, Quinn R, Tripepi G, Mallamaci F, Maas R, Zoccali C, Ravani P.
    J Nephrol; 2012 Aug 01; 25(6):1016-22. PubMed ID: 22322824
    [Abstract] [Full Text] [Related]

  • 37. Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading.
    Wanby P, Brattström L, Brudin L, Hultberg B, Teerlink T.
    Scand J Clin Lab Invest; 2003 Aug 01; 63(5):347-53. PubMed ID: 14599157
    [Abstract] [Full Text] [Related]

  • 38. Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III.
    Chen WL, Tain YL, Chen HE, Hsu CN.
    Front Pediatr; 2021 Aug 01; 9():706323. PubMed ID: 34458211
    [Abstract] [Full Text] [Related]

  • 39. Big-endothelin 1 (big ET-1) and homocysteine in the serum of dogs with chronic kidney disease.
    Rossi G, Giordano A, Breda S, Lisi C, Roura X, Zatelli A, Paltrinieri S.
    Vet J; 2013 Oct 01; 198(1):109-15. PubMed ID: 23899407
    [Abstract] [Full Text] [Related]

  • 40. [Homocysteine and asymmetric dimethylarginine (ADMA) in epilepsy].
    Dorszewska J, Winczewska-Wiktor A, Sniezawska A, Kaczmarek I, Steinborn B.
    Przegl Lek; 2009 Oct 01; 66(8):448-52. PubMed ID: 20043592
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.